PDGFR‐β and kidney fibrosis
Abstract Chronic kidney disease (CKD) is one of the fastest growing global causes of death, estimated to rank among the top five by 2040 (Foreman et al, 2018). This illustrates current pitfalls in diagnosis and management of CKD. Advanced CKD requires renal function replacement by dialysis or transp...
Saved in:
| Main Author: | Alberto Ortiz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2020-02-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201911729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis
by: Eva M Buhl, et al.
Published: (2020-01-01) -
CDCP1 knockdown suppresses PDGFRβ/AKT pathway-mediated vascular smooth muscle cell proliferation by inhibiting PDGFRβ endocytosis
by: Xin Ji, et al.
Published: (2025-04-01) -
P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments.
by: Andrew D Campbell, et al.
Published: (2013-01-01) -
Cambogin is preferentially cytotoxic to cells expressing PDGFR.
by: Ze Tian, et al.
Published: (2011-01-01) -
Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats.
by: Agnieszka A Pozdzik, et al.
Published: (2016-01-01)